← Leaderboards
John Altman
Emory University
$37,665,097
Attributed
$37,665,097
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $4.1M · FY2012–25$5M$3.8M$2.5M$1.3M$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$37,665,097 · 3
By mechanism
N01$37,665,097 · 3
Top collaborators
No co-investigators on record.
Most similar at Emory University
Same institution · by research overlap
- Andrew Michael Smith$12,045,869
- Peter E. Jensen$7,063,610
- Rafi Ahmed$104,632,759
- Raymond F. Schinazi$18,319,973
- Mandy L. Ford$29,844,446
Others in their field
Top investigators on “Reagent”
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$239,426,049
- Lawrence Corey · Fred Hutchinson Cancer Center$239,426,049
- Timothy Stedman · American Type Culture Collection$135,545,770
- Stanley M Lemon · Univ Of North Carolina Chapel Hill$110,090,673
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$105,181,167
- Peter B. Gilbert · Fred Hutchinson Cancer Center$94,846,879
Research focus
ReagentUnited States National Institutes Of HealthImmuneMediatingMajor Histocompatibility ComplexProductionPeptidesCore FacilityImmunologyCommunitiesT-LymphocyteNonhuman PrimateAllelesNeoplasm MetastasisCustomTumorNew TechnologyMicrobialPathogenBiomedical ResourceImmune ResponsePreventionNational Institute Of Allergy And Infectious DiseaseNovel Therapeutics
Grant awards (50)
NIH Tetramer Core Facility$1,213,385
N01 · FY2025 · AI · contact PI
NIH TETRAMER CORE FACILITY FOR INFECTIOUS DISEASES$500,000
N01 · FY2025 · AI · contact PI
NIH Tetramer Core Facility for Immunologic and Infectious Disease$303,346
N01 · FY2025 · AI · contact PI
NIH TETRAMER CORE FACILITY (HIV/AIDS)$300,000
N01 · FY2025 · AI · contact PI
NIH Tetramer Core Facility (Influenza)$200,000
N01 · FY2025 · AI · contact PI
NIH Tetramer Core Facility$1,127,149
N01 · FY2024 · AI · contact PI
NIH TETRAMER CORE FACILITY FOR INFECTIOUS DISEASES$500,000
N01 · FY2024 · AI · contact PI
NIH TETRAMER CORE FACILITY (HIV/AIDS)$300,000
N01 · FY2024 · AI · contact PI
NIH Tetramer Core Facility$1,487,872
N01 · FY2023 · AI · contact PI
TASK A-1: NIH TETRAMER CORE FACILITY (INFECTIOUS DISEASES OTHER THAN HIV/AIDS)$860,000
N01 · FY2023 · AI · contact PI
NIH TETRAMER CORE FACILITY (HIV/AIDS)$300,000
N01 · FY2023 · AI · contact PI
NIH Tetramer Core Facility$1,640,000
N01 · FY2022 · AI · contact PI
NIH TETRAMER CORE FACILITY (INFECTIOUS DISEASES OTHER THAN HIV/AIDS)$680,367
N01 · FY2022 · AI · contact PI
NIH TETRAMER CORE FACILITY (HIV/AIDS)$300,000
N01 · FY2022 · AI · contact PI
Tetramer Research & Development Contract (Influenza)$200,000
N01 · FY2022 · AI · contact PI
COVID supplement: Tetramer Research & Development$200,000
N01 · FY2022 · AI · contact PI
Tetramer Research and Development - immunologic and infectious diseases$179,633
N01 · FY2022 · AI · contact PI
Task Order B-5_75N93022F00002; 09/19/2022-03/20/2023; $18,543.00.$18,543
N01 · FY2022 · AI · contact PI
NIH TETRAMER CORE FACILITY (INFECTIOUS DISEASES OTHER THAN HIV/AIDS)$2,001,823
N01 · FY2021 · AI · contact PI
Tetramer Core Facility - Development and production of tetramer for CD4 and CD8 T cells$856,666
N01 · FY2021 · AI · contact PI
NIH TETRAMER CORE FACILITY (HIV/AIDS)$300,000
N01 · FY2021 · AI · contact PI
COVID Supplement - NIH Tetramer Core Facility$200,000
N01 · FY2021 · AI · contact PI
NIH TETRAMER CORE FACILITY (INFECTIOUS DISEASES OTHER THAN HIV/AIDS)$2,496,777
N01 · FY2020 · AI · contact PI
NIH TCF Dev and Prod of SARS-CoV-2 Spike tetramers for B Cell Detection$599,404
N01 · FY2020 · AI · contact PI
COVID 19 Supplement - NIH TCF TASK AREA B-1$400,000
N01 · FY2020 · AI · contact PI
NIH TCF TASK B-1$333,849
N01 · FY2020 · AI · contact PI
NIH TETRAMER CORE FACILITY (HIV/AIDS)$300,000
N01 · FY2020 · AI · contact PI
Tetramers for Biodefense Research$1,227,231
N01 · FY2019 · AI · contact PI
Tetramers for Immune-mediated Diseases Research$716,431
N01 · FY2019 · AI · contact PI
Tetramers for AIDS Research And AIDS-related Research$358,215
N01 · FY2019 · AI · contact PI
Tetramers for Biodefense Research$1,549,681
N01 · FY2018 · AI · contact PI
Tetramers for Immune-mediated Diseases Research$695,564
N01 · FY2018 · AI · contact PI
Tetramers for AIDS Research And AIDS-related Research$320,000
N01 · FY2018 · AI · contact PI
Tetramers for Biodefense Research$1,140,113
N01 · FY2017 · AI · contact PI
Tetramers for Immune-mediated Diseases Research$675,305
N01 · FY2017 · AI · contact PI
Tetramers for AIDS Research And AIDS-related Research$322,000
N01 · FY2017 · AI · contact PI
Tetramers for Biodefense Research$1,080,366
N01 · FY2016 · AI · contact PI
Tetramers for Immune-mediated Diseases Research$655,636
N01 · FY2016 · AI · contact PI
Tetramers for AIDS Research And AIDS-related Research$327,818
N01 · FY2016 · AI · contact PI
Tetramers for Biodefense Research$2,490,042
N01 · FY2015 · AI · contact PI
Tetramers for Immune-mediated Diseases Research$636,540
N01 · FY2015 · AI · contact PI
Tetramers for AIDS Research And AIDS-related Research$318,270
N01 · FY2015 · AI · contact PI
Tetramers for Immune-mediated Diseases Research$1,388,684
N01 · FY2014 · AI · contact PI
Tetramers for AIDS Research And AIDS-related Research$500,000
N01 · FY2014 · AI · contact PI
Tetramers for Immune-mediated Diseases Research$1,600,000
N01 · FY2013 · AI · contact PI
Tetramers for Biodefense Research$1,000,000
N01 · FY2013 · AI · contact PI
Tetramers for AIDS Research And AIDS-related Research$800,000
N01 · FY2013 · AI · contact PI
Tetramer Facility for Biodefense Research$1,032,193
N01 · FY2012 · AI · contact PI
Tetramer Facility for Immune-mediated diseases research$688,129
N01 · FY2012 · AI · contact PI
Tetramer Facility for AIDS/HIV Research$344,065
N01 · FY2012 · AI · contact PI